awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36287626-4514B1CD-532F-48E9-8D33-A30CC5B3FF7C
Q36287626-4514B1CD-532F-48E9-8D33-A30CC5B3FF7C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36287626-4514B1CD-532F-48E9-8D33-A30CC5B3FF7C
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
P2860
Q36287626-4514B1CD-532F-48E9-8D33-A30CC5B3FF7C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36287626-4514B1CD-532F-48E9-8D33-A30CC5B3FF7C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
825c26661977f13072b21fbdf8b07e8aaac00c13
P2860
The combination of circulating Ang1 and Tie2 levels predicts progression-free survival advantage in bevacizumab-treated patients with ovarian cancer.